Ribozyme mediated suppression of vascular endothelial growth factor gene expression enhances matrix metalloproteinase 1 expression in a human hepatocellular carcinoma cell line

被引:2
作者
Kamochi, J
Tokunaga, T
Morino, F
Nagata, J
Tomii, Y
Abe, Y
Hatanaka, H
Kijima, H
Yamazaki, H
Watanabe, N
Matsuzaki, S
Ueyama, Y
Nakamura, M [1 ]
机构
[1] Tokai Univ, Sch Med, Dept Pathol, Kanagawa 2591193, Japan
[2] Tokai Univ, Sch Med, Dept Internal Med, Div Gastroenterol, Kanagawa 2591193, Japan
关键词
VEGF expression; ribozyme; MMP1; hepatocellular carcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The levels of expression of various genes were altered in cellular transformants with manipulation of expression of single genes. Vascular endothelial growth factor A (VEGF-A) is a key molecule for tumor progression, although it is unclear how VEGF-A expression regulates various genes. Multiple gene expression levels were evaluated using cDNA arrays in a human hepatocellular carcinoma cell line (HLF) with suppression of the VEGF-A gene by anti-VEGF-A ribozyme (alphaVRz). The ribozyme-mediated suppression of VEGF-A gene solely up-regulated matrix metalloproteinase 1 (MMP1) gene level in HLF/alphaVRz. Levels of expression of other members of MMP family or tissue inhibitors of MMPs did not show any alteration. These results suggested that intracellular suppression of VEGF-A gene was specifically linked to up-regulation of MMP1 in human hepatocellular carcinoma cells.
引用
收藏
页码:81 / 84
页数:4
相关论文
共 24 条
[21]   Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinoma [J].
Wang, Z ;
Qiu, SJ ;
Ye, SL ;
Tang, ZY ;
Xiao, X .
CANCER GENE THERAPY, 2001, 8 (10) :751-758
[22]   Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice [J].
Yoon, SK ;
Armentano, D ;
Wands, JR ;
Mohr, L .
CANCER GENE THERAPY, 2001, 8 (08) :573-579
[23]  
Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.3.CO
[24]  
2-N